Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057551 · ClinicalTrials.gov registry record · Phase 4
Research Evaluating the Value of Augmenting Medication With Psychotherapy
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 491
- Enrollment target
NCT00057551 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 491 participants.
The verdict
NCT00057551, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 491 participants
- Enrollment target
Study Summary
This 24-week study, with a 12-month follow up period, will compare the effectiveness of antidepressant medication alone to the combination of psychotherapy and antidepressant medication in patients with chronic depression.
Interventions
- BEHAVIORAL CBASP
- BEHAVIORAL Brief Supportive Psychotherapy
- DRUG Medication Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 491 participants |
| Start Date | 2003-04 |
| Est. Completion | 2007-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00057551
The ClinicalTrials.gov registry entry for NCT00057551 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 491 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CBASP is the first listed.
NCT00057551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00057551 about?
NCT00057551 is a clinical study titled "Research Evaluating the Value of Augmenting Medication With Psychotherapy". This 24-week study, with a 12-month follow up period, will compare the effectiveness of antidepressant medication alone to the combination of psychotherapy and antidepressant medication in patients with chronic depression.
What is the current status of trial NCT00057551?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 491 participants. The study started on 2003-04. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00057551?
The interventions under investigation include: CBASP (BEHAVIORAL), Brief Supportive Psychotherapy (BEHAVIORAL), Medication Only (DRUG).
Who is sponsoring clinical trial NCT00057551?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.